Search Results - "FOSSA, Sophie D"

Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease by Grytli, Helene Hartvedt, Fagerland, Morten Wang, Fosså, Sophie D, Taskén, Kristin Austlid

“…Abstract Background We recently reported reduced prostate cancer (PCa)–specific mortality for β-blocker users among patients receiving androgen-deprivation…”
Get full text

Cause-Specific Survival for Women Diagnosed With Cancer During Pregnancy or Lactation: A Registry-Based Cohort Study by STENSHEIM, Hanne, MØLLER, Bjørn, VAN DIJK, Tini, FOSSA, Sophie D

“…To assess if cancers diagnosed during pregnancy or lactation are associated with increased risk of cause-specific death. In this population-based cohort study…”
Get full text

Pregnancy after adolescent and adult cancer: A population‐based matched cohort study by Stensheim, Hanne, Cvancarova, Milada, Møller, Bjørn, Fosså, Sophie D.

“…Despite fertility‐preserving initiatives, postcancer reproduction is expected to be lower than that of the general population. Using data from the Cancer…”
Get full text

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study by HAUGNES, Hege S, WETHAL, Torgeir, AASS, Nina, DAHL, Olav, KLEPP, Olbjørn, LANGBERG, Carl W, WILSGAARD, Tom, BREMNES, Roy M, FOSSA, Sophie D

“…To evaluate the prevalence of cardiovascular risk factors and long-term incidence of cardiovascular disease (CVD) in survivors of testicular cancer (TC)…”
Get full text

Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort by Hellesnes, Ragnhild, Myklebust, Tor Åge, Fosså, Sophie D, Bremnes, Roy M, Karlsdottir, Ása, Kvammen, Øivind, Tandstad, Torgrim, Wilsgaard, Tom, Negaard, Helene F S, Haugnes, Hege S

“…Using complete information regarding testicular cancer (TC) treatment burden, this study aimed to investigate cause-specific non-TC mortality with impact on…”
Get full text

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial by Sartor, Oliver, Prof, Coleman, Robert, Prof, Nilsson, Sten, Prof, Heinrich, Daniel, MD, Helle, Svein I, MD, O'Sullivan, Joe M, Prof, Fosså, Sophie D, Prof, Chodacki, Aleš, MD, Wiechno, Paweł, MD, Logue, John, FRCR, Widmark, Anders, Prof, Johannessen, Dag Clement, MD, Hoskin, Peter, Prof, James, Nicholas D, Prof, Solberg, Arne, MD, Syndikus, Isabel, FRCR, Vogelzang, Nicholas J, Prof, O'Bryan-Tear, C Gillies, MRCP, Shan, Minghua, PhD, Bruland, Øyvind S, Prof, Parker, Christopher, MD

“…Summary Background Bone metastases frequently cause skeletal events in patients with metastatic castration-resistant prostate cancer. Radium-223 dichloride…”
Get full text

Longitudinal Serum Testosterone, Luteinizing Hormone, and Follicle-Stimulating Hormone Levels in a Population-Based Sample of Long-Term Testicular Cancer Survivors by SPRAUTEN, Mette, BRYDØY, Marianne, HAUGNES, Hege S, CVANCAROVA, Milada, BJØRO, Trine, BJERNER, Johan, FOSSA, Sophie D, OLDENBURG, Jan

“…To assess longitudinal long-term alterations of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in testicular cancer survivors…”
Get full text

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up by Haugnes, Hege S, Bosl, George J, Boer, Hink, Gietema, Jourik A, Brydøy, Marianne, Oldenburg, Jan, Dahl, Alv A, Bremnes, Roy M, Fosså, Sophie D

“…Germ cell testicular cancer (TC) represents a malignancy with high cure rates. Since the introduction of cisplatin-based chemotherapy in the late 1970s, the…”
Get full text

Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular Cancer by SPRAUTEN, Mette, DARRAH, Thomas H, TRAVIS, Lois B, PETERSON, Derick R, ELLEN CAMPBELL, M, HANNIGAN, Robyn E, CVANCAROVA, Milada, BEARD, Clair, HAUGNES, Hege S, FOSSA, Sophie D, OLDENBURG, Jan

“…Cisplatin-induced neurotoxicity and ototoxicity (NTX) are important adverse effects after chemotherapy for testicular cancer (TC). Although serum platinum is…”
Get full text

An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer by van Andel, George, Bottomley, Andrew, Fosså, Sophie D, Efficace, Fabio, Coens, Corneel, Guerif, Stephane, Kynaston, Howard, Gontero, Paolo, Thalmann, George, Akdas, Atif, D’Haese, Sven, Aaronson, Neil K

“…Abstract Aim To evaluate the psychometrics of the EORTC QLQ-PR25, a questionnaire assessing the health-related quality of life of prostate cancer patients…”
Get full text

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial by Widmark, Anders, MD, Klepp, Olbjørn, MD, Solberg, Arne, MD, Damber, Jan-Erik, MD, Angelsen, Anders, MD, Fransson, Per, PhD, Lund, Jo-Åsmund, MD, Tasdemir, Ilker, MD, Hoyer, Morten, MD, Wiklund, Fredrik, PhD, Fosså, Sophie D, MD

“…Summary Background Several studies have shown the efficacy of endocrine therapy in combination with radiotherapy in high-risk prostate cancer. To assess the…”
Get full text

Solid Tumors After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study by CHUNKIT FUNG, FOSSA, Sophie D, MILANO, Michael T, OLDENBURG, Jan, TRAVIS, Lois B

“…Increased risks of solid tumors after older radiotherapy strategies for testicular cancer (TC) are well established. Few population-based studies, however,…”
Get full text

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer by Frisina, Robert D, Wheeler, Heather E, Fossa, Sophie D, Kerns, Sarah L, Fung, Chunkit, Sesso, Howard D, Monahan, Patrick O, Feldman, Darren R, Hamilton, Robert, Vaughn, David J, Beard, Clair J, Budnick, Amy, Johnson, Eileen M, Ardeshir-Rouhani-Fard, Shirin, Einhorn, Lawrence H, Lipshultz, Steven E, Dolan, M Eileen, Travis, Lois B

“…Cisplatin is widely used but highly ototoxic. Effects of cumulative cisplatin dose on hearing loss have not been comprehensively evaluated in survivors of…”
Get full text

Adverse Prognostic Factors for Testicular Cancer–Specific Survival: A Population-Based Study of 27,948 Patients by FOSSA, Sophie D, CVANCAROVA, Milada, LINLIN CHEN, ALLAN, Annie L, OLDENBURG, Jan, PETERSON, Derick R, TRAVIS, Lois B

“…The prognostic significance of age at testicular cancer (TC) diagnosis, socioeconomic status (SES), race, and marital status on TC-specific mortality is not…”
Get full text

Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs by Storås, Anne Holck, Fosså, Sophie D., Ursin, Giske, Andreassen, Bettina Kulle

“…Background During the past two decades, new antitumor drugs (Abiraterone, Enzalutamide, Radium-223, Cabazitaxel, and Docetaxel) have been introduced for…”
Get full text

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy by Grytli, Helene Hartvedt, Fagerland, Morten Wang, Fosså, Sophie D., Taskén, Kristin Austlid, Håheim, Lise Lund

“…BACKGROUND Experimental evidence suggests a role for the β2‐adrenergic receptor pathway in prostate cancer (PCa). We have investigated the association of…”
Get full text

Norwegian reference values for the Short-Form Health Survey 36: development over time by Jacobsen, Ellisiv L., Bye, Asta, Aass, Nina, Fosså, Sophie D., Grotmol, Kjersti S., Kaasa, Stein, Loge, Jon Håvard, Moum, Torbjørn, Hjermstad, Marianne J.

“…Purpose Reference values for patient-reported outcome measures are useful for interpretation of results from clinical trials. The study aims were to collect…”
Get full text

A study of body image in long‐term breast cancer survivors by Falk Dahl, Christian A., Reinertsen, Kristin V., Nesvold, Inger‐Lise, Fosså, Sophie D., Dahl, Alv A.

“…BACKGROUND: In this controlled postdiagnosis study, the authors examined various aspects of body image of breast cancer survivors in cross‐sectional and…”
Get full text

Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy by Nilsen, Tormod S, Raastad, Truls, Skovlund, Eva, Courneya, Kerry S, Langberg, Carl W, Lilleby, Wolfgang, Fosså, Sophie D, Thorsen, Lene

“…Androgen deprivation therapy (ADT) increases survival rates in prostate cancer (PCa) patients with locally advanced disease, but is associated with side…”
Get more information

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial by Sternberg, Cora N, Dr, Skoneczna, Iwona, MD, Kerst, J Martijn, PhD, Albers, Peter, Prof, Fossa, Sophie D, Prof, Agerbaek, Mads, MD, Dumez, Herlinde, Prof, de Santis, Maria, MD, Théodore, Christine, MD, Leahy, Michael G, Chester, John D, Prof, Verbaeys, Antony, Prof, Daugaard, Gedske, Prof, Wood, Lori, MD, Witjes, J Alfred, PhD, de Wit, Ronald, Prof, Geoffrois, Lionel, MD, Sengelov, Lisa, DMSc, Thalmann, George, Prof, Charpentier, Danielle, MD, Rolland, Frédéric, MD, Mignot, Laurent, MD, Sundar, Santhanam, MRCP, Symonds, Paul, Prof, Graham, John, FRCP, Joly, Florence, Prof, Marreaud, Sandrine, MD, Collette, Laurence, PhD, Sylvester, Richard, ScD

“…Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to…”
Get full text